FI873180L - Nya hetrazepiner och foerfarande foer deras framstaellning. - Google Patents

Nya hetrazepiner och foerfarande foer deras framstaellning. Download PDF

Info

Publication number
FI873180L
FI873180L FI873180A FI873180A FI873180L FI 873180 L FI873180 L FI 873180L FI 873180 A FI873180 A FI 873180A FI 873180 A FI873180 A FI 873180A FI 873180 L FI873180 L FI 873180L
Authority
FI
Finland
Prior art keywords
hetrazepiner
nya
foerfarande foer
och foerfarande
deras framstaellning
Prior art date
Application number
FI873180A
Other languages
English (en)
Finnish (fi)
Other versions
FI873180A7 (fi
FI873180A0 (fi
Inventor
Karl-Heinz Weber
Albrecht Harreus
Werner Stransky
Gerhard Walther
Jorge Casals-Stenzel
Gojko Muacevic
Hubert Heuer
Wolf-Dietrich Bechtel
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI873180A0 publication Critical patent/FI873180A0/fi
Publication of FI873180A7 publication Critical patent/FI873180A7/fi
Publication of FI873180L publication Critical patent/FI873180L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI873180A 1986-07-22 1987-07-20 Nya hetrazepiner och foerfarande foer deras framstaellning. FI873180L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3624647 1986-07-22

Publications (3)

Publication Number Publication Date
FI873180A0 FI873180A0 (fi) 1987-07-20
FI873180A7 FI873180A7 (fi) 1988-01-23
FI873180L true FI873180L (fi) 1988-01-23

Family

ID=6305650

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873180A FI873180L (fi) 1986-07-22 1987-07-20 Nya hetrazepiner och foerfarande foer deras framstaellning.

Country Status (26)

Country Link
US (1) US5532233A (cs)
EP (1) EP0254245B1 (cs)
JP (1) JPH085895B2 (cs)
KR (1) KR950013564B1 (cs)
AT (1) ATE112280T1 (cs)
AU (1) AU609408B2 (cs)
CA (1) CA1338287C (cs)
CS (3) CS277446B6 (cs)
CZ (1) CZ284052B6 (cs)
DD (1) DD281389A5 (cs)
DE (1) DE3750599D1 (cs)
DK (1) DK379787A (cs)
ES (1) ES2061452T3 (cs)
FI (1) FI873180L (cs)
HU (1) HU203354B (cs)
IE (1) IE65111B1 (cs)
IL (1) IL83270A0 (cs)
MX (1) MX7463A (cs)
NO (1) NO166942C (cs)
NZ (1) NZ221153A (cs)
PH (1) PH30676A (cs)
PL (2) PL157209B1 (cs)
PT (1) PT85373B (cs)
SU (1) SU1738089A3 (cs)
YU (1) YU136187A (cs)
ZA (1) ZA875333B (cs)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60219955A (ja) * 1984-04-16 1985-11-02 Matsushita Electric Works Ltd ステツプモ−タ
DE3778559D1 (de) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
US4959361A (en) * 1987-12-18 1990-09-25 Hoffmann-La Roche Inc. Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists
CA1324863C (en) * 1988-01-30 1993-11-30 Minoru Moriwaki Thienotriazolodiazepine compounds and pharmaceutical uses thereof
DE3810848A1 (de) * 1988-03-30 1989-10-19 Boehringer Ingelheim Kg Neue 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole, ihre herstellung und verwendung
CA1322367C (en) * 1988-05-17 1993-09-21 Yoshitomi Pharmaceutical Industries Ltd. Thienotriazolodiazepine compounds and pharmaceutical uses thereof
IL91386A0 (en) * 1988-08-24 1990-04-29 Boehringer Ingelheim Kg Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it
FI95708C (fi) 1988-10-31 1996-03-11 Eisai Co Ltd Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
RU2117670C1 (ru) * 1988-10-31 1998-08-20 Эйсай Ко., Лтд. Производные триазоло[1,4]диазепина и способы их получения
US5221671A (en) * 1988-10-31 1993-06-22 Eisai Co., Ltd. Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
US5468740A (en) * 1988-10-31 1995-11-21 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
US5304553A (en) * 1988-10-31 1994-04-19 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
US5382579A (en) * 1988-10-31 1995-01-17 Eisai Co., Ltd. Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
EP0384421A3 (de) * 1989-02-23 1992-02-12 Boehringer Ingelheim Kg Verwendung von PAF-Antagonisten zur Behandlung von pathologischen Blutgasveränderungen
GB8907257D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-paf and anti-ischemic agents
AT394562B (de) * 1989-03-31 1992-05-11 Scras Verfahren zur herstellung neuer thieno-triazolodiazepine
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors
GB8911030D0 (en) * 1989-05-13 1989-06-28 Scras Hetrazepine derivatives
GR1000393B (el) * 1990-03-08 1992-06-30 Sod Conseils Rech Applic Μεθοδος παρασκευης νεων θειενο-τριαζολο-διαζεπινων.
NL9000627A (nl) * 1990-03-29 1991-10-16 Scras Werkwijze ter bereiding van nieuwe thienotriazolo-diazepines.
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
OA09202A (fr) * 1990-04-02 1992-06-30 Sod Conseils Rech Applic Procédé de préparation des nouveaux dérivés de la thiéno-triazolo-diazépine.
GR1000348B (el) * 1990-04-27 1992-06-25 Sod Conseils Rech Applic Μεθοδος παρασκευης θειενο-τριαζολο-διαζεπινο-παραγωγων.
AT394563B (de) * 1990-05-09 1992-05-11 Scras Verfahren zur herstellung von thieno-triazolodiazepinderivaten
DE4027470A1 (de) * 1990-08-30 1992-03-05 Boehringer Ingelheim Kg Neue hetrazepinoide amide
DE4107521A1 (de) * 1991-03-08 1992-09-10 Boehringer Ingelheim Kg Neue acylaminosubstituierte hetrazepine
DE4128579A1 (de) * 1991-08-28 1993-03-04 Boehringer Ingelheim Kg Verwendung von 4-(2-chlorphenyl)-9-methyl-2-(3(4-morpholinyl)-3-propanon-1-y1)-6h-thieno-(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin zur behandlung der allergischen rhinitis
ATE221779T1 (de) * 1991-11-04 2002-08-15 Ruth-Maria Korth Behandlung und vorbeugung von erhöhten lyso-paf- spiegel mediierten mentalen erkrankungen mit paf- antagonisten
WO1995032963A1 (en) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Thienylazole compound and thienotriazolodiazepine compound
US5714262A (en) * 1995-12-22 1998-02-03 E. I. Du Pont De Nemours And Company Production of poly(ethylene terephthalate)
AU6517398A (en) * 1997-03-27 1998-10-22 Kyowa Hakko Kogyo Co. Ltd. Therapeutic agent for autoimmune diseases
CA2297815A1 (en) 1997-07-31 1999-02-11 Ube Industries, Ltd. N-acylamino acid amide compounds and intermediates for preparation thereof
US6323214B1 (en) 1997-10-29 2001-11-27 Medco Research, Inc Allosteric adenosine receptor modulators
US5939432A (en) * 1997-10-29 1999-08-17 Medco Research, Inc. Thiophenes useful for modulating the adenosine receptor
US6727258B2 (en) 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
US20060165700A1 (en) * 2002-09-04 2006-07-27 Ostroff Gary R Cancer therapy using whole glucan particles and antibodies
KR102505085B1 (ko) 2009-12-04 2023-02-28 선오비온 파마슈티컬스 인코포레이티드 다환형 화합물 및 이의 사용 방법
EP4464317A3 (en) 2016-07-29 2025-01-22 Sumitomo Pharma America, Inc. Compounds and compositions and uses thereof
SG11201900687VA (en) 2016-07-29 2019-02-27 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
CN110678205B (zh) 2017-02-16 2023-05-23 桑诺维恩药品公司 治疗精神分裂症的方法
CN111183138A (zh) 2017-08-02 2020-05-19 赛诺维信制药公司 异色满化合物以及用途
WO2019161238A1 (en) 2018-02-16 2019-08-22 Sunovion Pharmaceuticals Inc. Salts, crystal forms, and production methods thereof
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
ES2986407T3 (es) 2020-03-31 2024-11-11 Hoffmann La Roche Derivados de benzodiacepinas como PAM de GAMMA 1 GABA A
CN115734785A (zh) 2020-04-14 2023-03-03 桑诺维恩药品公司 (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症
WO2022101377A1 (en) * 2020-11-16 2022-05-19 Boehringer Ingelheim International Gmbh Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists
EP4408848A1 (en) 2021-09-29 2024-08-07 F. Hoffmann-La Roche AG New benzodiazepine derivatives as gaba a gamma1 pam
IL311377A (en) 2021-10-06 2024-05-01 Hoffmann La Roche Benzodiazepine derivatives as positive allosteric modulators of the GABA A GAMMA 1 receptor
WO2023117914A1 (en) 2021-12-22 2023-06-29 Boehringer Ingelheim International Gmbh Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES393101A1 (es) * 1971-07-09 1974-05-16 Made Labor Sa Procedimiento para la preparacion de derivados de tieno- diazepina.
JPS5438116B2 (cs) * 1972-03-22 1979-11-19
JPS5116063B2 (cs) * 1972-05-30 1976-05-21
JPS5342400B2 (cs) * 1973-05-30 1978-11-10
US3902679A (en) * 1974-01-07 1975-09-02 Charles H Bost Wire dispenser
JPS50100096A (cs) * 1974-01-08 1975-08-08
JPS5747677B2 (cs) * 1974-03-01 1982-10-12
AT338799B (de) * 1974-03-02 1977-09-12 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
ZA755418B (en) * 1974-09-11 1977-06-29 Hoffmann La Roche Diazepine derivatives
US4118386A (en) * 1977-04-04 1978-10-03 Hoffmann-La Roche Inc. Synthesis of imidazo[1,5-a]diazepine-3-carboxylates
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3778559D1 (de) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
DE3610848A1 (de) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg Neue 1,4-diazepine
DE3777541D1 (de) * 1986-11-17 1992-04-23 Yoshitomi Pharmaceutical Paf-antagonistische thienotriazoldiazepin-verbindungen und deren pharmazeutische anwendung.
DE3878833T2 (de) * 1987-05-28 1993-06-09 Yoshitomi Pharmaceutical Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
EP0316456A4 (en) * 1987-06-08 1990-05-14 Yoshitomi Pharmaceutical Ester-substituted thienotriazolodiazepine compounds and their medicinal use.
DE3735525C2 (de) * 1987-10-20 1997-02-20 Korth Ruth Maria Verfahren zur Bestimmung der Wirksamkeit von paf-Acether-Rezeptor-Antagonisten
MC1999A1 (fr) * 1987-12-18 1990-01-26 Hoffmann La Roche Composes tricycliques
CA1324863C (en) * 1988-01-30 1993-11-30 Minoru Moriwaki Thienotriazolodiazepine compounds and pharmaceutical uses thereof
EP0338993A1 (en) * 1988-04-21 1989-10-25 Sandoz Ag 6-Aryl-substituted-4h-thieno[2,3-e][1,2,4]triazolo [3,4-c][1,4]diazepines
KR930009786B1 (ko) * 1988-04-27 1993-10-11 쉐링 코포레이션 특정 paf 길항제/항히스타민제 조성물
CA1322367C (en) * 1988-05-17 1993-09-21 Yoshitomi Pharmaceutical Industries Ltd. Thienotriazolodiazepine compounds and pharmaceutical uses thereof
FI95708C (fi) * 1988-10-31 1996-03-11 Eisai Co Ltd Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
GB8907256D0 (en) * 1989-03-31 1989-05-17 Rech Et D Applic Scient Scras New derivatives of hetrazepine as anti-asthmatic anti-allergic and gastro-intestinal protectors

Also Published As

Publication number Publication date
JPS6333382A (ja) 1988-02-13
PT85373B (pt) 1990-04-30
KR880001663A (ko) 1988-04-26
HU203354B (en) 1991-07-29
HUT50830A (en) 1990-03-28
AU7601587A (en) 1988-01-28
NZ221153A (en) 1990-07-26
EP0254245B1 (de) 1994-09-28
CA1338287C (en) 1996-04-30
PH30676A (en) 1997-09-16
NO166942B (no) 1991-06-10
CZ284052B6 (cs) 1998-08-12
FI873180A7 (fi) 1988-01-23
CS277445B6 (en) 1993-02-17
YU136187A (en) 1991-06-30
ATE112280T1 (de) 1994-10-15
MX7463A (es) 1993-10-01
PL157209B1 (pl) 1992-05-29
DD281389A5 (de) 1990-08-08
CS550887A2 (en) 1990-09-12
ES2061452T3 (es) 1994-12-16
AU609408B2 (en) 1991-05-02
IE65111B1 (en) 1995-10-04
PL153970B1 (en) 1991-06-28
KR950013564B1 (en) 1995-11-09
US5532233A (en) 1996-07-02
IE871983L (en) 1988-01-22
NO873041L (no) 1988-01-25
CS277446B6 (en) 1993-03-17
CS274456B2 (en) 1991-04-11
ZA875333B (en) 1989-03-29
SU1738089A3 (ru) 1992-05-30
JPH085895B2 (ja) 1996-01-24
DK379787A (da) 1988-01-23
EP0254245A1 (de) 1988-01-27
DK379787D0 (da) 1987-07-21
NO166942C (no) 1991-09-18
IL83270A0 (en) 1987-12-31
FI873180A0 (fi) 1987-07-20
PL266884A1 (en) 1988-09-15
PT85373A (de) 1987-08-01
DE3750599D1 (de) 1994-11-03
NO873041D0 (no) 1987-07-21

Similar Documents

Publication Publication Date Title
FI873180L (fi) Nya hetrazepiner och foerfarande foer deras framstaellning.
FI871788A0 (fi) Nya kinolinderivat och foerfarande foer framstaellning daerav.
FI880546A7 (fi) Nya kolfibriller, foerfarande foer framstaellning daerav och kompositioner innehaollande desamma.
FI861002A0 (fi) Nya svavelhaltiga 5-substituerade bensimidazolderivat och foerfarande foer deras framstaellning.
FI864299A0 (fi) Nya kinolinderivat och foerfaranden foer deras framstaellning.
FI873142A7 (fi) Nya benzolsulfonamido -indanylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI874102L (fi) Nya kefemfoereningar och foerfarande foer deras framstaellning.
FI874323A7 (fi) Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI875698L (fi) Nya koagulerings- och filtreringshjaelpmedel och deras anvaendning.
FI864658A7 (fi) Nya kefemfoereningar och foerfarande foer deras framstaellning.
FI871360A7 (fi) Nya fenoxialkylkarboxylsyraderivat foerfarande foer deras framstaellning och laekemedel innehaollande dessa foereningar.
FI870274A0 (fi) Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster.
FI875745L (fi) Nya kompositioner och foerfarande foer neutralisering och solidifiering av farliga alkaliutslaepp.
FI884511A7 (fi) Nya androstan-17 -karboxylsyraestrar och deras framstaellning och anvaendning.
FI871052A7 (fi) Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI875719A0 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI875086A7 (fi) Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873934A7 (fi) Nya naftylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI873917A7 (fi) Nya naftalin- och indanderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI873243A0 (fi) Nya 1,4-benzodiazepiner, deras framstaellning och anvaendning.
FI880849L (fi) Nya siloxan-bis-maleimider och foerfarande foer deras framstaellning.
FI885813L (fi) Nya polysackarider och polysackaridernas nya makromolekulaera konjugater.
FI873783A7 (fi) Nya sulfonamido-etylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI872509L (fi) Foer limning av papper laempliga nya aminohartser och deras anvaendning.
FI870176A7 (fi) Nya foereningar och deras framstaellningsfoerfaranden.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: BOEHRINGER INGELHEIM KG